Literature DB >> 3995291

Tyrosine accelerates catecholamine synthesis in hemorrhaged hypotensive rats.

L A Conlay, T J Maher, R J Wurtman.   

Abstract

Tyrosine, the amino acid precursor of catecholamines, increases blood pressure (BP) in rats made hypotensive by hemorrhage. Since this amino acid also accelerates catecholamine synthesis in and release from frequently-firing neurons, we tested the hypothesis that tyrosine's pressor action resulted from this mechanism. Male Sprague-Dawley rats (500 g) were anesthetized with chloralose (50 mg/kg) and urethane (500 mg/kg) and tracheostomized. The carotid artery was cannulated allowing BP to be recorded continuously. Blood was removed until systolic BP fell to half of each animal's starting value; 45 min later, animals received tyrosine or other treatments in volumes of 1 ml/kg. Tyrosine (100 mg/kg) increased BP by 58%, while saline caused an insignificant increase. Pretreatment with carbidopa, which inhibits tyrosine's conversion to catecholamines, blocked the amino acid's effect. Tyrosine also failed to increase BP in rats made hypotensive with phentolamine, suggesting that it acts via catecholamine receptors. Adrenal epinephrine significantly (P less than 0.02) and splenic norepinephrine slightly (P less than 0.07) increased in rats receiving tyrosine after 1 h of hypotension when compared with tissue-catecholamine contents in similar rats. These observations show that tyrosine increases BP during hemorrhagic hypotension by accelerating catecholamine synthesis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3995291     DOI: 10.1016/0006-8993(85)90126-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Dietary supplementation of tyrosine prevents the rapid fall in blood pressure during haemorrhage.

Authors:  F A Moya-Huff; J M Pinto; P J Kiritsy; T J Maher
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

2.  Oral tyrosine supplementation improves exercise capacity in the heat.

Authors:  Les Tumilty; Glen Davison; Manfred Beckmann; Rhys Thatcher
Journal:  Eur J Appl Physiol       Date:  2011-03-25       Impact factor: 3.078

3.  Behavioural changes controlled by catecholaminergic systems explain recurrent loss of pigmentation in cavefish.

Authors:  Helena Bilandžija; Lindsey Abraham; Li Ma; Kenneth J Renner; William R Jeffery
Journal:  Proc Biol Sci       Date:  2018-05-16       Impact factor: 5.349

4.  Specificity of the acute tryptophan and tyrosine plus phenylalanine depletion and loading tests I. Review of biochemical aspects and poor specificity of current amino Acid formulations.

Authors:  Abdulla A-B Badawy; Donald M Dougherty; Dawn M Richard
Journal:  Int J Tryptophan Res       Date:  2010-01-01

5.  Effects of Tyrosine on Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Joanne DiFrancisco-Donoghue; Ely Rabin; Eric M Lamberg; William G Werner
Journal:  Mov Disord Clin Pract       Date:  2014-10-23

6.  Simultaneous electrochemical detection of levodapa, paracetamol and l-tyrosine based on multi-walled carbon nanotubes.

Authors:  Zai-Yu Li; Dan-Yang Gao; Zhi-Yong Wu; Shuang Zhao
Journal:  RSC Adv       Date:  2020-04-07       Impact factor: 3.361

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.